Weight loss injections have become increasingly prevalent in clinical practice, with glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) leading the therapeutic landscape
The intranasal route was chosen for its ability to bypass the blood-brain barrier, allowing the peptide to reach brain tissue more effectively while minimizing systemic copper exposure
Often called Ozempic breasts , these changes are a natural response to significant weight loss, but they can affect how a person feels about their shape
Int J Radiat Oncol Biol Phys 18:10691075
Zepbound (tirzepatide) Approved uses: People with overweight or obesity and moderate-to-severe obstructive sleep apnea Drug type: Once-weekly injection Doses: 2.5 mg (initial dose), 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg Cost: With commercial insurance that includes Zepbound coverage, the cost of a three-month prescription is as low as $25